This HTML5 document contains 173 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n12http://dx.doi.org/10.1161/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33923921
rdf:type
wikibase:Item
schema:description
2012年の論文 научная статья 2012年論文 سائنسی مضمون artikull shkencor tieteellinen artikkeli scientific article vědecký článek article scientifique (publié 2012) 2012年论文 2012年论文 teaduslik artikkel 2012年論文 bilimsel makale videnskabelig artikel (udgivet 2012) 2012年论文 scienca artikolo artigo científico мақолаи илмӣ wissenschaftlicher Artikel artigo científico (publicado na 2012) мақолаи илмӣ научна статия 2012年論文 научни чланак 2012년 논문 vedecký článok naučni članak artículu científicu espublizáu en 2012 article scientific مقالهٔ علمی 2012年論文 tudományos cikk vitskapeleg artikkel מאמר מדעי სამეცნიერო სტატია artikulong pang-agham 2012年论文 articol științific научни чланак ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ επιστημονικό άρθρο artykuł naukowy наукова стаття, опублікована у вересні 2012 2012 nî lūn-bûn vitenskapelig artikkel artículo científico publicado en 2012 2012年论文 mokslinis straipsnis bài báo khoa học article científic 2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված 2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած مقالة علمية 2012年論文 vetenskaplig artikel wetenschappelijk artikel 2012年论文 artigo científico (publicado na 2012) บทความทางวิทยาศาสตร์ articolo scientifico
p:P577
wds:Q33923921-B6FBCD2E-6758-48C3-802E-4F3445DB7CBA
wdt:P577
2012-09-24T00:00:00Z
p:P407
wds:Q33923921-5DA61404-B0E8-46E5-9E07-1D7D77F6A362
wdt:P407
wd:Q1860
p:P2860
wds:Q33923921-AD5A2448-84A8-415D-9158-4243BC9E66DA wds:Q33923921-AEB83E98-9B40-44A5-9FE4-77966F8F742B wds:Q33923921-BCBDC1E0-6D6B-4617-AD28-8712BF0B52B1 wds:Q33923921-C9B6409A-0A85-4FD0-897E-89653624D5B4 wds:Q33923921-91CC5043-A659-43D2-849E-7354F537059A wds:Q33923921-983AED30-4E36-4126-8D2D-0BBB8F2FF2B0 wds:Q33923921-99B131CE-47E5-4BA2-B65D-20E60CBAD54C wds:Q33923921-AB992D2C-AAF4-44AD-8BD6-476F66B36C9A wds:Q33923921-FAFA14EA-A0F7-4E66-9B5B-AEFC756EA523 wds:Q33923921-ED628465-8F65-46DF-8FBB-F2008407B430 wds:Q33923921-F0F153C1-D5A1-4ED8-8D94-3E62E46DB793 wds:Q33923921-FA96C327-575C-4277-B995-275D13239744 wds:Q33923921-13CF2C4F-B35B-4380-9B18-313222C29AC4 wds:Q33923921-1BDE9B8F-BCC4-45E1-A1C8-622490F5F9F2 wds:Q33923921-25ACBCE3-A8FF-4B35-9DC4-D75F532E1712 wds:Q33923921-0B92D730-058D-403B-924A-3FD7461D2EDD wds:Q33923921-67B3A292-61B1-44F1-8516-81E37C485509 wds:Q33923921-746B9F77-9C99-4E53-BD06-BEDE23091C10 wds:Q33923921-78C27613-8BB4-4639-8175-55F3A1E88808 wds:Q33923921-3603BD28-598B-40CB-9332-72B582A0654C wds:Q33923921-38F522D1-268A-444B-94F9-61ADA54B6BC5
wdt:P2860
wd:Q34612445 wd:Q61819895 wd:Q34948400 wd:Q50666682 wd:Q61819896 wd:Q38492894 wd:Q46115334 wd:Q69868664 wd:Q58009255 wd:Q30439801 wd:Q84566193 wd:Q84383774 wd:Q33696402 wd:Q33827504 wd:Q71433061 wd:Q28304018 wd:Q84167706 wd:Q36762868 wd:Q36152222 wd:Q50766984 wd:Q52082530
p:P2093
wds:Q33923921-9734E9DC-D57D-4847-A968-BB201A06C13F wds:Q33923921-8AF59B36-DAAB-4B91-AEA8-56CA1472A035 wds:Q33923921-8FA29352-825F-453A-A5A1-85B0AA21F2FB wds:Q33923921-6965F875-46F6-457B-A4C1-6713D3D0FEDA wds:Q33923921-5F7297DA-28A4-40F4-B60F-4F7A0742285F wds:Q33923921-63203712-C1D3-44F6-B16F-28B5F2FA7627 wds:Q33923921-2A4CE20F-8903-462F-94D2-E7DBEE9B0E2E wds:Q33923921-2A7A1C32-9F97-41A7-886A-DB01D9D93F8F wds:Q33923921-13D2E083-4323-453C-B2F1-96630C2699A8 wds:Q33923921-178F9B05-AC52-4069-A3E0-EDB66734A90C wds:Q33923921-1283CDCB-9869-4519-B961-D8FEA86979C1 wds:Q33923921-EEE9B3CB-8EA2-4471-81A2-AE3101266CD7 wds:Q33923921-E2A84842-C8D6-4427-8A92-147A1C68659E wds:Q33923921-BF65D1A5-237C-4D13-A458-65AE238CDD47
wdt:P2093
Frederick Feit BARI 2D Study Group Fumiaki Ikeno Alan J Garber Spencer B King Ronald J Krone Robert L Frye Edward Y Sako Maria Mori Brooks Bernard R Chaitman Regina M Hardison William J Rogers Richard W Nesto Charles J Davidson
rdfs:label
Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial
skos:prefLabel
Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial
schema:name
Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial
p:P50
wds:Q33923921-E0A1FA6A-05FA-4065-99D2-DEF47AD06AE1
wdt:P50
wd:Q100694590
p:P1476
wds:Q33923921-C87AFFDF-7314-4FF7-8508-8E36D89F1305
wdt:P1476
Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial
p:P304
wds:Q33923921-56AE6E28-165D-40D8-9B06-A2DC1149315F
wdt:P304
2115-2124
p:P31
wds:Q33923921-5B215B2C-CB09-41ED-86FC-EB81E3EA6EB2
wdt:P31
wd:Q13442814
p:P921
wds:Q33923921-6F1C4E13-E0B3-4CD2-A66D-77F17E3490B7 wds:Q33923921-9020BEE9-D08D-483A-9763-DA799D519978 wds:Q33923921-B5314470-4B9A-4E09-8892-8FF3F4DF3C9B
wdt:P921
wd:Q7317735 wd:Q468414 wd:Q539795
p:P698
wds:Q33923921-44CD4D65-9AAF-41C1-B6A4-C6B9B48C5048
wdtn:P698
n10:23008442
wdt:P698
23008442
p:P1433
wds:Q33923921-DF548E46-51F0-40B7-9C51-FB3CB9DF749D
wdt:P1433
wd:Q578091
p:P433
wds:Q33923921-82B135B9-0410-461B-86C6-E9878F224A35
p:P478
wds:Q33923921-DFF14BC6-3069-48D5-A761-B6E446953673
wdt:P433
17
wdt:P478
126
p:P356
wds:Q33923921-6BCA333E-1A19-4270-9FDC-8089E5E03497
wdtn:P356
n12:CIRCULATIONAHA.112.092973
wdt:P356
10.1161/CIRCULATIONAHA.112.092973
p:P932
wds:Q33923921-80D24BF7-442D-42E2-9853-BE1813F5B4BF
wdt:P932
4104411